MiRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments

Jan 19, 2021

MiRagen Therapeutics, Inc. announced its name change to Viridian Therapeutics, Inc. (NASDAQ: VRDN). The Company also announced today the appointment of Jonathan Violin, Ph.D., M.B.A. as President and Chief Executive Officer and member of the Board of Directors.

Read more >